{
    "clinical_study": {
        "@rank": "20042", 
        "arm_group": {
            "arm_group_label": "Healthy reproductive age women", 
            "description": "These volunteers were previously taking the oral contraceptives of interest for a minimum of 3 months"
        }, 
        "brief_summary": {
            "textblock": "The degree of suppression and subsequent activation of the hypothalamic-pituitary-ovarian\n      axis during the hormone-free interval in combined oral contraceptive (COC) hormone users\n      varies depending on the dose of ethinyl estradiol in the formulation. This variation in\n      activation may be associated with different side effects during the hormone free interval.\n      Progesterone (P) remained suppressed during all 6 COC regimens (<1.8 ng/mL), which indicates\n      continuous contraceptive efficacy during the 7-day hormone free interval of all formulations\n      studied."
        }, 
        "brief_title": "Oral Contraceptive Hormone-free Interval Pituitary/ Ovarian Activity", 
        "condition": "Hypothalamic-pituitary-ovarian Axis, Gonadotropins, Ethinyl Estradiol, Contraceptive Efficacy", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Healthy, reproductive age women\n\n          -  18 to 35 years old,\n\n          -  seeking contraception from the general gynecology clinics of the LAC and USC Medical\n             Center w\n\n          -  taking one of 6 possible monophasic COC formulations for at least 3 cycles prior to\n             enrollment\n\n          -  regular menstrual cycles prior to COCs\n\n        Exclusion Criteria:\n\n          -  Irregular bleeding\n\n          -  bilateral oophorectomy\n\n          -  amenorrhea\n\n          -  hormone-sensitive cancer\n\n          -  concurrent medications known to interfere with steroid metabolism (i.e.,\n             barbiturates, phenytoin, carbamazepine, ethosuximide, primidone, rifampin,\n             tetracycline)"
            }, 
            "gender": "Female", 
            "maximum_age": "35 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Healthy, reproductive age women 18 to 35 years old, who were seeking contraception from\n        the general gynecology clinics of the LAC and USC Medical Center were recruited. The\n        research team identified potential candidates who were taking one of 6 possible monophasic\n        COC formulations. Informed consent was obtained from participants by the research staff.\n        To be eligible for participation, women reported regular menstrual cycles prior to COCs,\n        and had taken at least 3 cycles of the same monophasic COC prior to enrollment."
            }
        }, 
        "firstreceived_date": "September 17, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01953211", 
            "org_study_id": "Hormone free interval"
        }, 
        "intervention": {
            "arm_group_label": "Healthy reproductive age women", 
            "intervention_name": "combined oral contraceptives", 
            "intervention_type": "Drug", 
            "other_name": "ALESSE, LOESTRIN, NORDETTE, ORTHOCEPT, ORTHOCYCLEN, ORTHO NOVUM"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Contraceptive Agents", 
                "Contraceptives, Oral", 
                "Contraceptives, Oral, Combined"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "September 25, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Los Angeles", 
                    "country": "United States", 
                    "state": "California"
                }, 
                "name": "LAC and USC Medical Center"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "LH, FHS, Estradiol and Progesterone Activity During the 7-Day Hormone-Free Interval of Various Combined Oral Contraceptive Regimens", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 1998", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "follicle-stimulating hormone", 
            "time_frame": "Serum blood samples were collected for hormone measurements at the same time daily during the 7 day hormone free interval"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01953211"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Southern California", 
            "investigator_full_name": "Frank Stanczyk", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "lutenizing hormone", 
                "time_frame": "daily serum during the hormone free interval"
            }, 
            {
                "measure": "estradiol", 
                "time_frame": "daily serum samples during the hormone free interval"
            }, 
            {
                "measure": "progesterone", 
                "time_frame": "daily serum during the 7 day hormone free interval"
            }
        ], 
        "source": "University of Southern California", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Southern California", 
                "agency_class": "Other"
            }
        }, 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "September 2013"
    }
}